Endothelial progenitor cells in coronary artery disease: from bench to bedside
Endothelial progenitor cells (EPCs) are a heterogeneous group of cells present in peripheral
blood at various stages of endothelial differentiation. EPCs have been extensively …
blood at various stages of endothelial differentiation. EPCs have been extensively …
Patient-related factors predicting stent thrombosis in percutaneous coronary interventions
Over the past four decades, percutaneous coronary intervention (PCI) safety and efficacy
have significantly improved, particularly with the advent of the drug-eluting stent (DES). First …
have significantly improved, particularly with the advent of the drug-eluting stent (DES). First …
Endothelial progenitor cells in coronary atherosclerosis and percutaneous coronary intervention: a systematic review and meta-analysis
Introduction The role of endothelial progenitor cells (EPCs) in atherosclerosis progression
and neointimal growth after percutaneous coronary intervention (PCI) remains controversial …
and neointimal growth after percutaneous coronary intervention (PCI) remains controversial …
[HTML][HTML] Endothelial progenitor cells and coronary artery disease: Current concepts and future research directions
ST **ao, CY Kuang - World journal of clinical cases, 2021 - ncbi.nlm.nih.gov
Vascular injury is a frequent pathology in coronary artery disease. To repair the vasculature,
scientists have found that endothelial progenitor cells (EPCs) have excellent properties …
scientists have found that endothelial progenitor cells (EPCs) have excellent properties …
The bioengineered combo dual-therapy CD34 antibody-covered sirolimus-eluting coronary stent in patients with chronic total occlusion evaluated by clinical outcome …
R Blessing, M Ahoopai, M Geyer, M Brandt… - Journal of clinical …, 2020 - mdpi.com
We sought to determine the effects of the use of a Bioengineered Combo Dual-Therapy
CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent (Combo® DTS) in patients with …
CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent (Combo® DTS) in patients with …